Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20573)

• Formulation Name: Suvorexant 15 mg tablet
• Company: Merck Sharp & Dohme

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Suvorexant	(DM0E6S3)	Insomnia	7A00-7A0Z	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent